🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Immunotoxins can locate tumor cells and kill them without harmin...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-11
Trial ID
NCT00036972
Treatments Being Tested
IL-13-PE is a chemical similar to one made by the body that is connected to...
Status
Terminated
Location
National Cancer Institute at the National Institutes of Health
Start Date
2012-12
Trial ID
NCT01832974
Treatments Being Tested
IL13-PE38QQR is an oncology drug product consisting of IL13 (interleukin-13...
Status
Completed
Location
University of California San Francisco
Start Date
2001-06
Trial ID
NCT00024557
Treatments Being Tested
RATIONALE: Immunotoxins can locate tumor cells and kill them without harmin...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2000-10
Trial ID
NCT00006268
Treatments Being Tested
The purpose of the PRECISE trial is to determine whether overall survival d...
Status
Completed
Location
University of Alabama at Birmingham - Division of Neurosurgery
Start Date
2004-02
Trial ID
NCT00076986
Background: * Diffusely infiltrating pontine glioma (DIPG) or supratentori...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-04-07
Trial ID
NCT00880061
Treatments Being Tested
IL13-PE38QQR is an oncology drug product consisting of IL13 (interleukin-13...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2000-11
Trial ID
NCT00024570
Treatments Being Tested
IL13-PE38QQR is an oncology drug product consisting of IL13 (interleukin-13...
Status
Completed
Location
University of Colorado Health Sciences Center
Start Date
2002-07
Trial ID
NCT00041587
Treatments Being Tested
RATIONALE: Immunotoxins can locate tumor cells and kill them without harmin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00053040
Treatments Being Tested
The experimental anti-cancer drug IL13-PE38QQR, which is being developed fo...
Status
Completed
Location
Duke University Medical Center
Start Date
2003-07
Trial ID
NCT00064779
Treatments Being Tested